Sturm, Ruger & Company Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw 19% sales growth, margin expansion, and improved profitability, with strong cash flow and no debt. New product launches were delayed due to high demand, and the Ruger Business System was established to drive operational consistency.
-
Net sales grew 4% year-over-year to $141 million, with adjusted EPS at $0.27 after excluding non-recurring costs. Strong new product demand drove a 28% increase in units ordered and a 20% rise in backlog, while a strategic agreement with Beretta Holding provided stability.
Fiscal Year 2025
-
Despite industry headwinds, achieved modest sales growth and strong product sell-through, driven by innovation and capacity expansion. Adjusted earnings declined due to non-recurring expenses, but cash flow and balance sheet remain robust.
-
Year-over-year sales growth was achieved despite a softer market, with new products driving 34% of net firearm sales. Margin pressure stemmed from costs at the new Hebron facility, but strong cash flow and disciplined capital allocation supported continued investment and shareholder returns.
-
Q2 2025 saw higher net sales and strong new product performance, but non-recurring charges led to a reported loss. The Anderson acquisition and operational realignment position the company for long-term growth, despite industry-wide demand softness and macroeconomic headwinds.
-
Q1 2025 saw flat sales and improved profitability despite industry declines, with strong new product demand and a focus on innovation. Capital expenditures are set to rise above $30 million to accelerate product launches and expand capacity, supported by a robust balance sheet.
Fiscal Year 2024
-
2024 net sales declined slightly year-over-year, but Q4 saw strong sequential growth in sales and profitability. New product launches, especially the RXM pistol, drove market share gains, while a robust balance sheet and disciplined capital allocation position the company well for 2025.
-
Q3 2024 saw net sales of $122.3M and EPS of $0.28, with market share gains driven by strong new product demand. Inventory levels fell, cash and investments totaled $96M, and the company maintained a debt-free balance sheet while returning $39.3M to shareholders.
-
Q2 2024 net sales and earnings declined year-over-year, but production rose 18% from Q1 and new products drove strong distributor sell-through. Cash remains above $100 million, with continued dividends and share repurchases. Margin improvements are expected from cost reductions and higher production.